text: A multidisciplinary approach is recommended for clinical management from infancy up to adulthood. Hormone replacement<unk>  is needed following gonadectomy. Patients who have decided to retain their gonads are considered to be at risk for developing germ cell tumors and for these the sensitive circulating tumor markers may become available soon.
option_0: Androgen insensitivity syndrome medical therapy
option_1: Turner syndrome medical therapy
option_2: Androgen insensitivity syndrome primary prevention
option_3: Androgen insensitivity syndrome secondary prevention
option_4: Hypogonadism medical therapy
option_5: 17-beta-hydroxysteroid dehydrogenase deficiency medical therapy
option_6: Prolactinoma medical therapy
option_7: Adiposogenital dystrophy medical therapy